Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-043882
Filing Date
2014-06-26
Accepted
2014-06-26 17:02:58
Documents
1
Period of Report
2014-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4025
  Complete submission text file 0001209191-14-043882.txt   5470
Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 330 MAIN STREET CONCORD MA 01742
Business Address
Garmey Edward Graeme (Reporting) CIK: 0001602627 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 14943309